Vivek Radhakrishnan
@drvivek_onco
Followers
471
Following
407
Media
12
Statuses
166
Haemato-Oncologist & TCT Physician| Consultant & Haem trials lead, University Hospital Southampton| Passion: Immunotherapy & Precision medicine| Views personal!
Southampton, United Kingdom
Joined June 2014
RT @graham74GC: It was the Inaugural UK and Ireland Hodgkin Lymphoma Forum today. 🇬🇧 🇮🇪 Incredible participation from all involved. Much th….
0
5
0
RT @UHSFT: An incredible story. 👇. Beth faced a diagnosis of Hodgkin Lymphoma complicated by encephalopathy causing her to be unconscious f….
bbc.co.uk
Beth Paterson spent nine weeks unconscious while hospital staff gave her chemotherapy.
0
5
0
RT @UHS_lymphoma: Super excited to be launching our X account and sharing all the innovative things happening within our Lymphoma Service a….
0
7
0
RT @SouthamptonCTU: Are you going to @raceforlife #Bournemouth this Sunday?. Look out for @CR_UK Senior Research Nurse Kerry & her team who….
0
2
0
Fantastic opportunity to work with a wonderful team of world renowned #lymphoma experts @UHSFT @PWMJohnson @AndyD1036 @SeanHuaLim @ForconiF @robertlown @DavidDutton500 & the @SouthamptonCTU.State-of-the-art work across phase 1-3 #clinicaltrials in #lymsm.
0
1
6
RT @katie88233454: Exciting opportunity to join the brilliant @WessexBMTCT @robertlown @PWMJohnson @SeanHuaLim #CAR-T fellowship h….
0
4
0
RT @SridharChaganti: A fantastic collaborative effort from colleagues across the UK. Final results of the Tidal trial in newly diagnosed CD….
0
10
0
Congratulations, #Hemeteam @TMCKolkata-Culmination of 1 wonderful journey & beginning of a new one, benchmarked! .Thanks @docarijit for remembering us.Truly a win for good patient care! .Thanks @FACTcelltherapy @Nadim_M_Chicago #TMCqualityteam for inspiring & helping this feat!.
Sometimes it takes a universe to achieve a milestone. Cheers to our entire #hemeteam at @TMCKolkata. This is a testatment of the good work that has been done over the last decade. Proud of all that we achieved together. And it just keeps getting better….
1
0
8
#BiSpecificMAbs are a breakthrough in the 💉of #lymphoma In an invited article we review the role of BsA in Indolent #lymphomas & posit different scenarios. @AndyD1036 @LymphomaAction @bloodcancer_uk @kansagraMD @FrontImmunol #lymsm #drugdiscovery.
frontiersin.org
The advent of immunotherapy in lymphomas, beginning with Rituximab, have led to paradigm shifting treatments that are increasingly bringing a greater number ...
2
4
20
Amazing work from @UHSFT @WessexBMTCT. Huge efforts frm teams @WessexBMTCT & #lymsm. @robertlown & team pivotal in setting up #celltherapy CAR-T service here. Way to go!. @AndyD1036 @PWMJohnson @SeanHuaLim @DavidDutton500 @katie88233454 #JingHiew @LymphomaAction @WecareUHSFT.
2
1
9
RT @DrChrisPFox: A great team effort: LBCL is getting complicated! .R/R guideline to follow. @AndyD1036 @Sridha….
onlinelibrary.wiley.com
Click on the article title to read more.
0
21
0
Builds on #AxiCel #ZUMA-12 #ASH23 .@UHSFT #lymphoma group has an active & diverse portfolio of #pharma & #IIS #clinicaltrials. @UoS_Medicine @southamptonCRF.@PWMJohnson @SeanHuaLim.@DavidDutton500 @katie88233454.@WessexBMTCT #lymsm.@lymphomahub @VJHemOnc.
0
0
3
This trial in #lymsm comes on the back of 🇺🇸 @FDAOncology approval of @KitePharma #AxiCel accelerated approval in R/R Follicular #lymphoma. @UHSFT On-boarded yesterday 👍. @uoscares @UoS_Medicine @WessexBMTCT @CureLeukaemia.@katie88233454.
fda.gov
On March 5, 2021, the Food and Drug Administration granted accelerated approval to axicabtagene ciloleucel (Yescarta, Kite Pharma, Inc.) for adult patients with relapsed or refractory follicular...
0
1
4
@AndyD1036 chair, introducing the galaxy of KOLs of 🇬🇧 lymphoma.@DrChrisPFox @graham74GC @tobyeyre82 @DanielHodson20 @CwynKate among others. @CureLeukaemia @PWMJohnson @NHSuk @knowyournodes @SouthamptonCTU @uoscares @
0
3
13
It's 🇬🇧 #lymphoma #trials day today. A wonderful gathering of lymphoma trial enthusiasts from #UK. Lookin forward to wonderful discussions & trial data.Inclusive group of clinicians, nurses, patient reps, industry. to name a few.@LymphomaAction @bloodcancer_uk @WomenInLymphoma
1
1
12
@BCCancer molecular DZsig work from @DavidScottPhD lab in #DLBCL #lymsm with #KerryJSavage #JosephMConnors et al. @LymphomaCanada @LLSCanada .
ashpublications.org
Key Points. DHITsig expression extends beyond HGBCL-DH-BCL2 to identify dark zone lymphomas and was thus renamed the “DZsig.”DZsig refines cell-of-origin c
0
0
0
#REMoDL-B #molecular work - @leedsomics @BarransSharon @AndyD1036 @SouthamptonCTU @unisouthampton . @SeanHuaLim @robertlown @janfalconer @UHSFTresearch @UniofOxford @Cambridge_Uni @UniversityLeeds .@LymphomaAction @lymphomahub @VJHemOnc @knowyournodes.
ascopubs.org
PurposeBiologic heterogeneity is a feature of diffuse large B-cell lymphoma (DLBCL), and the existence of a subgroup with poor prognosis and phenotypic proximity to Burkitt lymphoma is well known....
0
0
4
Important 🇬🇧🇨🇦translational research #collaboration in #lymsm #DLBCL from @SouthamptonCTU @leedsomics @DavidScottPhD @PWMJohnson @AndyD1036 @uoscares @UHSFTresearch on the back of #REMoDL-B study . Molecular high grade & DZSig signatures DLBC #Lymphoma .
ashpublications.org
TO THE EDITOR:
2
2
9
Thanks @DrLongley!.#Hodgkins #Lymphoma treatment continues to evolve despite phenomenal cure rates. Enjoyed the effort thoroughly with @PWMJohnson & you. #lymsm @LymphomaAction @knowyournodes @UHSFT @unisouthampton @CureLeukaemia @bloodcancer_uk @UoS_Medicine @CureLeukaemia.
Thank you @drvivek_onco @PWMJohnson for our most recent update “antibody based therapies in Hodgkin Lymphoma” check it out⬇️.
0
1
7
0
0
0